Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals

BACKGROUND: Since healthcare-associated pneumonia (HCAP) is heterogeneous, clinical characteristics and outcomes are different from region to region. There can also be differences between HCAP patients hospitalized in secondary or tertiary hospitals. This study aimed to evaluate the clinical charact...

Full description

Bibliographic Details
Main Authors:	Jong Hoo Lee, Yee Hyung Kim
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Health care Pneumonia Antibiotics Mortality Resistance
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000400002&lng=en&tlng=en

Similar Items

The association of prior hospitalization with clinical outcomes among patients admitted with pneumonia: a propensity score matching study
by: Jae-Uk Song, et al.
Published: (2019-04-01)

The outcome of hospital-acquired pneumonia in patients admitted for long-term care according to the antibiotic duration
by: Eman Shebl, et al.
Published: (2019-01-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study
by: Biswajit Chakrabarti, et al.
Published: (2018-03-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
by: Yun Jung Jung, et al.
Published: (2022-01-01)

Description of antibiotic therapy of hospitalized-community-acquired pneumonia in PKU Muhammadiyah Gamping hospital
by: Joko Sudibyo, et al.
Published: (2022-03-01)

Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens
by: Hironori Kobayashi, et al.
Published: (2022-11-01)

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study
by: Li F, et al.
Published: (2023-08-01)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
by: Hsin Chi, et al.
Published: (2020-10-01)

Severe virus associated community acquired pneumonia: predictors of lethality
by: T. O. Pertseva, et al.
Published: (2016-06-01)

Predictors of hospital mortality and multidrug-resistant pathogens in hospitalized pneumonia patients residing in the community
by: Tomohiko Ukai, et al.
Published: (2023-12-01)

Effect of vaccination on morbidity and mortality from community-acquired pneumonia
by: T. A. Bayanova, et al.
Published: (2024-03-01)

Meningitis in critically ill patients admitted to intensive care unit for severe community-acquired pneumococcal pneumonia
by: Paul Jaubert, et al.
Published: (2023-12-01)

A Large Gap in Patients’ Characteristics and Outcomes between the Real-World and Clinical Trial Settings in Community-Acquired Pneumonia and Healthcare-Associated Pneumonia
by: Nobuhiro Asai, et al.
Published: (2022-01-01)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
by: Bo-Guen Kim, et al.
Published: (2022-01-01)

Cost-effectiveness analysis of empiric antibiotics in hospitalized community-acquired Pneumonia
by: Yeni Farida, et al.
Published: (2022-03-01)

Prognostic factors of mortality in elderly with community acquired pneumonia
by: Đordjević Ivanka, et al.
Published: (2010-01-01)

Azithromycin Place in the Therapy of Community-Acquired Pneumonia in Children
by: S.A. Kramarev
Published: (2013-03-01)

Hospital Acquired Pneumonia
by: Halis AKALIN, et al.
Published: (1999-12-01)

Factors associated with in-hospital mortality from community-acquired pneumonia in Portugal: 2000–2014
by: Ezequiel Pessoa, et al.
Published: (2020-01-01)

Investigation and Comparison of Diagnosis and Treatment Guidelines for Community Acquired Pneumonia in terms of Pharmaceutical Care Requirements
by: Melda BAHAP, et al.
Published: (2021-03-01)

Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital
by: Claudia Figueiredo Mello, et al.

Guidelines and management of hospitalized patients with community-acquired pneumonia: the Italian experience of the FASTCAP study
by: I. Iori, et al.
Published: (2013-05-01)

Antibiotic Use and Treatment Outcomes among Children with Community-Acquired Pneumonia Admitted to a Tertiary Care Public Hospital in Nepal
by: Bhishma Pokhrel, et al.
Published: (2021-04-01)

Non-HIV <it>Pneumocystis</it> pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?
by: Asai Nobuhiro, et al.
Published: (2012-06-01)

Predictors and prognostic implications of hospital-acquired pneumonia in patients admitted for acute heart failure
by: Marija Polovina, et al.
Published: (2023-09-01)

Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department
by: Kyeong-Ryong Lee, et al.
Published: (2022-10-01)

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
by: Fonseca Lima EJ, et al.
Published: (2016-06-01)

The association between serum magnesium levels and community-acquired pneumonia 30-day mortality
by: Roni Nasser, et al.
Published: (2018-12-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

Prior pneumococcal vaccination improves in-hospital mortality among elderly population hospitalized due to community-acquired pneumonia
by: Seohyun Kim, et al.
Published: (2024-04-01)

Community-acquired pneumonia in children: antibacterial therapy
by: Y. L. Mizernitsky
Published: (2013-12-01)

Prognostic Value of Procalcitonin in Pneumonia among Patients Admitted to Intensive Care Unit.
by: Deok Hee Kim, et al.
Published: (2019-06-01)

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
by: Ane Uranga MD, et al.
Published: (2020-10-01)

Community-acquired pneumonia in patients admitted to National District Hospital in Bloemfontein: guideline adherence
by: Thornton Ford, et al.
Published: (2018-11-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Outcomes of patients admitted to the intensive care unit with community-acquired pneumonia in a tertiary care center in Riyadh, Saudi Arabia
by: Talal Oreibi, et al.
Published: (2023-01-01)

The incidence of acute renal failure and high mortality rate in elderly patients hospitalized with community acquired pneumonia
by: E. Lubart, et al.
Published: (2023-08-01)